# Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery

> **NCT07180615** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Universität Luzern** · enrollment: 458 (estimated)

## Conditions studied

- Surgical Site Infection
- Colon Surgery
- Surgical Site Infections

## Interventions

- **DRUG:** Rifaximin (Xifaxan)
- **DRUG:** Metronidazole
- **DRUG:** Neomycin Sulfate

## Key facts

- **NCT ID:** NCT07180615
- **Lead sponsor:** Universität Luzern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2029-06-30
- **Target enrollment:** 458 (ESTIMATED)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180615, "Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07180615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*